Head of Research, IPOs & Placements, Aequitas Research

Sumeet Singh

Head of IPO & Placements for Aequitas Research. At Aequitas we cover all IPOs and placements across Asia-Pac with a deal size of at least US$100m. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%. 
Prior to Aequitas. I was heading Content Strategy for Smartkarma, along with covering IPOs & Placement. In an earlier life I have covered ASEAN property and the banking space in India.

Head of Research, IPOs & Placements

Aequitas: Kokusai Electric Placement - Last Deal Did Ok, but the Stock Has Done Very Well Since

Aequitas ECM Weekly (2 February 2026)- Eastroc, Muyuan, Han's CNC, Wuxi Lead, Sungrow, Kokusai

Aequitas ECM Weekly (9 February 2026)- Eastroc, Muyuan, Han's, Montage, Axera, Woer, Fractal

Japan Cross-Shareholding - Summary Matrix - Over US$100bn of Selling in 118 Companies

Aisin Corp Placement - US$1.1bn Selldown by Toyota and DENSO

SMFG Cross-Shareholding - At Least US$17bn of Cross-Shareholding to Sell, Planning to Speed It Up

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

Shin Etsu Chemical / Equity Capital Markets

<ul>
<li>A group of shareholders plan to raise around S$800m via selling some of their stake in <a href="https://www.smartkarma.com/entities/shin-etsu-chemical-co-ltd" target="_blank" data-smartkarma-citation="entities:4481:1" rel="noopener">Shin Etsu Chemical (4063 JP)</a>.</li>
<li>This will be another large cross-shareholding unwind in Japan, although the shares haven’t done much recently.</li>
<li>In this note, we talk about the deal dynamics and run the deal through our ECM framework.</li>
</ul>


A group of shareholders plan to raise around S$800m via selling some of their stake in Shin Etsu Chemical (4063 JP).
This will be another large cross-shareholding unwind in Japan, although the shares haven’t done much recently.
In this note, we talk about the deal dynamics and run the deal through our ECM framework.


アエクイタス：信越化学の株式公開 - 比較的小規模な8億ドルの取引